vimarsana.com

Page 3 - நுரையீரல் புற்றுநோய் ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Kendal dental nurse s fundraising challenge for Cancer Research UK

CANSA participates in lung cancer research | Rising Sun Chatsworth

CANSA participates in lung cancer research | Rising Sun Chatsworth
risingsunchatsworth.co.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from risingsunchatsworth.co.za Daily Mail and Mail on Sunday newspapers.

MSK researchers learn what s driving brain fog in people with COVID-19

 E-Mail One of the dozens of unusual symptoms that have emerged in COVID-19 patients is a condition that s informally called COVID brain or brain fog. It s characterized by confusion, headaches, and loss of short-term memory. In severe cases, it can lead to psychosis and even seizures. It usually emerges weeks after someone first becomes sick with COVID-19. In the February 8, 2021, issue of the journal Cancer Cell, a multidisciplinary team from Memorial Sloan Kettering reports an underlying cause of COVID brain: the presence of inflammatory molecules in the liquid surrounding the brain and spinal cord (called the cerebrospinal fluid). The findings suggest that anti-inflammatory drugs, such as steroids, may be useful for treating the condition, but more research is needed.

Sarah Cannon Promotes Melissa Johnson, MD, to Program Director, Lung Cancer Research

Press release content from Business Wire. The AP news staff was not involved in its creation. Sarah Cannon Promotes Melissa Johnson, MD, to Program Director, Lung Cancer Research December 17, 2020 GMT NASHVILLE, Tenn. (BUSINESS WIRE) Dec 17, 2020 Today, Sarah Cannon announced the promotion of Melissa Johnson, MD, to Program Director of Lung Cancer Research. In her new role, Dr. Johnson will lead the lung cancer clinical trial portfolio across the Sarah Cannon network. “Since joining Sarah Cannon, Dr. Johnson’s contributions to research have helped transform the treatment options available to patients facing lung cancer,” said David Spigel, MD, Chief Scientific Officer, Sarah Cannon. “As Program Director of Lung Cancer Research, Dr. Johnson will continue to help advance therapies for our patients today and in the future.”

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.